A historic shift in Canadian drug policy has occurred, as the regulators allow the legalization of psilocybin hallucinogens for therapeutic treatment. Before this, these substances were strictly restricted, but a growing body of studies suggests they potentially offer relief for mental health conditions like depression. The new policy represents a